DiPerna Paul's Form 4 filing
Modular Medical, Inc. (MODD) · filed Feb 22, 2022
- Accession no.
- 0001019056-22-000224
- Filed
- Feb 22, 2022
- Trade date
- Jan 26-Feb 14, 2022
- Filing delay
- 27 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 3 derivative transactions. It was filed 27 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DiPerna PaulCIK 0001506126 | Director, Officer (See Remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | MOption exerciseAcquired | +23,429 | –F1 | – | 2,543,585 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | MOption exerciseDisposed | −23,429 | –F1 | – | 0 | Direct | |
| Feb 14, 2022 | Common Stock | MOption exerciseAcquired | +23,429 | –F1 | – | 23,429 | Direct | |
| Jan 26, 2022 | Common Stock | PPurchaseAcquired | +11,294 | –F2 | – | 11,294 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The convertible promissory note (the "Note") was issued to the Paul DiPerna Trust on April 30, 2021, in the principal aggregate amount of $102,663, in connection with a private placement conducted by the Issuer. At the time of conversion, the Note had accrued interest of $9,788 and an outstanding balance of $112,451. Pursuant to its terms, the Note was automatically converted, on February 14, 2022, into (i) 23,429 shares of common stock of the Issuer and (ii) warrants to purchase 23,429 shares of common stock of the Issuer.
Referenced by the price of 1 transaction in Table I and 2 transactions in Table II.
- F2
The common stock purchase warrant (the "Warrant") was issued to the Paul DiPerna Trust on April 30, 2021 (the "Issuance Date"). Pursuant to its terms, the Warrant became exercisable on January 26, 2022, the day that is 271 calendar days following the Issuance Date.
Referenced by the price of 1 transaction in Table II.
Remarks
Title: Chairman, President and Chief Financial Officer